Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00430313
What this trial is testing

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

Who this might be right for
Liver CancerLiver Metastasis
M.D. Anderson Cancer Center
Post-approval studies (Phase 4)Study completedNCT00877760
What this trial is testing

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Foundation for Liver Research 184
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Not applicableStudy completedNCT03601546
What this trial is testing

Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam

Who this might be right for
Hepatitis C Infection
Centre Hospitalier Universitaire de Nīmes 300
Large-scale testing (Phase 3)Looking for participantsNCT07221188
What this trial is testing

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,250
Post-approval studies (Phase 4)UnknownNCT05788627
What this trial is testing

Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyChronic Liver Disease
Khyber Medical College, Peshawar 100
Not applicableStudy completedNCT03693586
What this trial is testing

Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis

Who this might be right for
Chronic Hepatitis cVasculitis
Hospital General de Mexico 1,000
Not applicableStudy completedNCT05168982
What this trial is testing

Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation

Who this might be right for
Liver Fibrosis
Chinese University of Hong Kong 200
Early research (Phase 1)Study completedNCT07595159
What this trial is testing

BW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT02202980
What this trial is testing

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 273
Not applicableNot Yet RecruitingNCT06649396
What this trial is testing

Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)

Who this might be right for
Delta Hepatitis
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 120
Testing effectiveness (Phase 2)Study completedNCT01170962
What this trial is testing

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 512
Testing effectiveness (Phase 2)UnknownNCT01680003
What this trial is testing

Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Nova Laboratories Sdn Bhd 50
Not applicableStudy completedNCT04494360
What this trial is testing

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

Who this might be right for
Healthy
Janssen Research & Development, LLC 830
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)Study completedNCT03954327
What this trial is testing

Combination Antiretroviral Therapy (cART) for PBC

Who this might be right for
Primary Biliary Cholangitis
University of Alberta 37
Testing effectiveness (Phase 2)Study completedNCT03266146
What this trial is testing

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Who this might be right for
Drug-induced Liver Injury,Chronic
Beijing 302 Hospital 90
Not applicableStudy completedNCT03584646
What this trial is testing

Prehabilitation Intervention to Maximize Early Recovery (PRIMER) in Liver Transplantation

Who this might be right for
Liver DiseasesEnd Stage Liver DiseaseFrailty
University of Pennsylvania 30
Not applicableStudy completedNCT05189990
What this trial is testing

Electrical Impedance Tomography in Fatty Liver Detection

Who this might be right for
Non-Alcoholic Fatty Liver Disease
The University of Hong Kong 160
Testing effectiveness (Phase 2)UnknownNCT01741090
What this trial is testing

The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis

Who this might be right for
Alcoholic Liver Cirrhosis
Yonsei University 12
Next Page